Medical technology breakthroughs have led to a radical transformation in patient care by enabling a greater focus on clinical outcomes. Minimally invasive or non-invasive medical technologies, for instance, not only shorten recovery time but also low ....see more
The global breast cancer liquid biopsy market is projected to reach USD 411.1 million by 2022 from USD 145.4 million in 2017, at a CAGR of 23.1%. Factors such as increasing prevalence of breast cancer, increasing preference for noninvasive procedures, initiatives undertaken by government and global health organizations, technological advancements to augment market revenues, rising emphasis on personalized medicine in clinical practice, and increased funding for liquid biopsy R&D are driving the growth of the breast cancer liquid biopsy market. The key players in the global breast cancer liquid biopsy market are QIAGEN N.V. (Netherlands), Roche Diagnostics (US), Bio-Rad Laboratories Inc. (US), Myriad Genetics, Inc. (US), Menarini Silicon Biosystems (Italy), Genomic Health, Inc. (US), Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), Biocept, Inc. (US), Trovagene, Inc. (US), Guardant Health, Inc. (US), RainDance Technologies, Inc. (US), and MDx Health SA (US).
The global bowel management systems market is projected to reach USD 2.07 billion by 2023 from USD 1.74 billion in 2018, at a CAGR of 3.5%. Growth in the bowel management systems market is mainly driven by factors such as the expanding target patient population, the rapidly growing geriatric population, availability of technologically advanced bowel management products, and the favorable reimbursement scenario in developed countries. Some of the major players operating in the bowel management systems market are Coloplast (Denmark), Medtronic (Ireland), 3M (US), B. Braun (Germany), C.R. Bard (US), Consure Medical (India), Cogentix Medical (US), Aquaflush Medical Limited (UK), Axonics Modulation Technologies (US), ConvaTec (UK), Hollister (US), MBH-International A/S (Denmark), Mederi Therapeutics Inc. (US), Welland Medical limited (UK), and Wellspect HealthCare (Sweden).
The global artificial tendons and ligaments market is projected to reach USD 35.0 million by 2023 from USD 18.5 million in 2018, at a CAGR of 13.6%. The growth of this market is primarily driven by factors such as the increasing incidence of sports injuries, growing number of initiatives to increase the awareness about artificial tendons and ligaments, increasing research activities on artificial tendons and ligaments, increasing preference for minimally invasive surgeries, benefits of artificial tendons and ligaments, and the issues related to the use of orthobiologics. The key players in the global artificial tendons and ligaments market are LARS (France), Neoligaments (UK), Cousin Biotech (France), Orthomed S.A.S. (France), FX Solutions (France), Shanghai PINE&POWER Biotech (China), and Mathys AG Bettlach (Switzerland).
The global veterinary endoscopy market is expected to reach USD 219.0 million by 2023 from USD 159.8 million in 2018, at a CAGR of 6.5%. The market growth is primarily driven by the growing pet population, increasing number of pet health insurance, and advanced applications of veterinary endoscopes. Key players in the veterinary endoscopy market include KARL STORZ (Germany), Olympus (Japan), Fujifilm (Japan), Eickemeyer (Germany), B. Braun (Germany), STERIS (UK), Endoscopy Support Services (US), Biovision Veterinary Endoscopy (US), Welch Allyn (US), and Dr. Fritz (Germany).
The global sinus dilation devices market is expected to reach USD 2.78 Billion by 2023 from USD 1.80 Billion in 2018, at a CAGR of 9.1% during the forecast period. Factors such as growing preference for minimally invasive procedures, benefits of balloon sinuplasty/sinus dilation over conventional sinus surgeries, favorable reimbursement scenario for sinus procedures in developed countries and high prevalence of chronic sinusitis are driving the growth of this market. The report segments the global sinus dilation devices market into product, type of procedure, patient care setting, type of patient, and region. The sinus dilation devices market includes various small and large players. Key players in this market include Entellus Medical Inc. (a subsidiary of Stryker) (US), Acclarent Inc. (a subsidiary of Johnson & Johnson) (US), Medtronic plc (Ireland), Smith & Nephew plc (UK), Intersect ENT Inc. (US), and Olympus Corporation (Japan). Other players in the market include Meril Life Sciences Pvt. Ltd. (India), SinuSys Corporation (US), InAccel (India), Jilin Coronado Medical Ltd. (China), and Creganna Medical (Ireland).
The global dental sterilization market is projected to reach USD 1.48 Billion by 2023 from USD 1.01 Billion in 2017 at a CAGR of 6.6% during the forecast period. Growth in the dental sterilization market is mainly driven by factors such as the increasing number of dental facilities and the growing pool of dental care personnel, growing prevalence of dental ailments, and increasing demand for cosmetic dentistry. The prominent players in the dental sterilization market are Getinge (Sweden), Midmark (US), SciCan (Canada), Tuttnauer (US), Planmeca (Finland), DENTSPLY Sirona (US), Danaher (US), Matachana (Spain), A-dec (US), W&H (Austria), Hu-Friedy (US), and NAKANISHI (Japan). New product launches and acquisitions were the major strategies adopted by these payers to maintain their positions in the dental sterilization market.
The global dental surgical instruments market is projected to reach USD 5.96 billion by 2023 from USD 4.48 billion in 2018, at a CAGR of 5.9%. Factors such as the rising incidence of dental diseases, growing demand for cosmetic dentistry, increasing number of dental practitioners and dental clinics, and growing dental expenditure are expected to drive market growth during the forecast period. The key players in the global dental surgical instruments market are DENTSPLY Sirona Inc. (US), Danaher Corporation (US), 3M Company (US), COLTENE Holding AG (Switzerland), Brasseler USA, A-dec, Inc. (US), Hu-Friedy Manufacturing Company, LLC (US), Integra LifeSciences Holdings Corporation (US), NAKANISHI Inc. (Japan), BIOLASE, Inc. (US), The Yoshida Dental Mfg. Co., Ltd. (Japan), Helmut Zepf Medizintechnik GmbH (Germany), Prima Dental Manufacturing Ltd. (UK), B. Braun Melsungen AG (Germany), AMD Lasers (US), and CAO Group, Inc. (US).
The global vascular patches market is expected to reach USD 525.8 Million by 2023 from USD 349.6 Million in 2018, at a CAGR of 8.5%. Growth in the vascular patches market is mainly driven by the rapidly growing geriatric population and the subsequent increase in the prevalence of vascular diseases, the increasing number of vascular surgeries performed, and the increasing adoption of biological patches. Major vendors who provide eDiscovery software and services include AccessData (US), Advanced Discovery (US), Catalyst (US), CloudNine (US), Commvault (US), Conduent (US), Deloitte (US), Driven (US), Epiq (US), FRONTEO (Japan), FTI (US), IBM (US), Ipro (US), KLDiscovery (US), Lighthouse (US), Logikcull (US), Micro Focus (UK), Microsoft (US), Nuix (Australia), OpenText (Canada), Relativity (US), Ricoh (Japan), Thomson Reuters (Canada), Veritas (US), and ZyLAB (Netherlands.
The angiography equipment market is projected to reach USD 13.06 Billion by 2023 from USD 10.26 Billion in 2018, at a CAGR of 5.0%. The growth in this market is attributed to the high prevalence of diseases such as cancer and CVDs, increasing product approvals for advanced angiography techniques in the market, the large number of ongoing research activities, growing government and public-private investments, increasing number of awareness programs, and rising adoption of angiography devices due to a large number of angiography procedures performed across the globe. The key players in the angiography equipment market are GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers (Germany), Canon Corporation (Japan), Boston Scientific Corporation (US), Cordis (a Cardinal Health Company, US), Shimadzu Corporation (Japan), Medtronic (Ireland), Angiodynamics (US), B. Braun Melsungen (Germany), and Abbott Laboratories (US).
The global lithotripsy devices market is expected to reach USD 1.76 Billion by 2023 from USD 1.41 Billion in 2018, at a CAGR of 4.5%. Growth in this market is propelled by the increasing incidence of urolithiasis and technological advancements in lithotripsy devices. Some of the major players in the lithotripsy devices market are Siemens AG (Germany), Boston Scientific (US), Dornier MedTech (Germany), Olympus America (Japan), DirexGroup (Germany), and Richard Wolf (Germany). Key companies in the Lubricating Oil Additives market include Afton Chemical (US), Chevron Oronite (US), BASF (Germany), Evonik Industries (Germany), Lubrizol Corporation (US), and Lanxess (Germany).
The global wound care biologics market is expected to reach USD 2.26 Billion by 2023 from USD 1.42 Billion in 2018, at a CAGR of 9.8%. Market growth is mainly driven by factors such as the increasing incidence of diabetic foot ulcers, increasing geriatric population, and increasing burn injuries globally. On the other hand, the high cost of wound care biologics and the higher rejection rate associated with skin grafts & substitutes will restrain the growth of this market. Key players in the wound care biologics market include Smith & Nephew (UK), Mölnlycke Health Care AB (Sweden), Integra LifeSciences Corporation (US), Wright Medical (US), MiMedx Group (US), Vericel Corporation (US), Anika Therapeutics (US), Osiris Therapeutics (US), Organogenesis (US), Kerecis (Iceland), Solsys Medical (US), ACell (US), Lavior Inc. (US), and Marine Polymer Technologies, Inc. (US).
The hernia repair market is projected to reach USD 4.75 Billion by 2023 from USD 4.09 Billion in 2018, at a CAGR of 3.0% during the forecast period. The increasing adoption of mesh in hernia repair surgeries, rising geriatric population, new product developments, and efficient reimbursement system in developed countries are the major factors driving the growth of the hernia repair market during the forecast period. The major players in the hernia repair market profiled in this report are Covidien ( Part of Medtronic) (Ireland), Ethicon (Part of Johnson & Johnson) (US), B. Braun (Germany), C.R. Bard (Part of Becton Dickinson) (US), W. L. Gore (US), LifeCell (Part of Allergan) (Ireland), Maquet (Part of Getinge) (Sweden), Cook Medical (US), Integra (US), DIPROMED (Italy), FEG (Germany), Cousin Biotech (France), Herniamesh (Italy), Aspide Medical (France), TransEasy Medical (China), and Via Surgical (Israel).
The global bariatric surgery devices market is projected to reach USD 2.16 Billion by 2023 from USD 1.64 Billion in 2018, at a CAGR of 5.7% during the forecast period. The growth of this market is driven by factors such as the growing obese population, increasing number of bariatric surgeries, and increasing preference for minimally invasive procedures. Ethicon (US), Medtronic (Ireland), Intuitive Surgical (US), Apollo Endosurgery (US), and ReShape Lifesciences, (US) are the key players in the bariatric surgery devices market. Other players involved in this market are Aspire Bariatrics (US), Mediflex Surgical Products (US), Spatz FGIA (US), Cousin Biotech (France), and Olympus Corporation of the Americas (US).
The biological safety cabinets market is projected to reach USD 205.9 Million by 2022 from USD 144.3 Million in 2017, at a CAGR of 7.4% during the forecast period. Growth in the biological safety cabinets market is mainly driven by factors such as favorable regulations, increased risk of pandemics and communicable diseases, and pharmaceutical companies, and rapid growth in the number of biologics. The biological safety cabinets market is segmented on the basis of type, end user, and region. The major market players in the biological safety cabinets market include Thermo Fisher Scientific (US), Esco Micro (Singapore), Labconco (US), The Baker Company (US), Kewaunee Scientific (US), NuAire (US), Germfree Laboratories (US), EUROCLONE (Italy), Cruma (Spain), Air Science (US), Berner International (Germany), and BIOBASE (China).
The sleep apnea oral appliances market is projected to reach USD 482.5 Million by 2023 from an estimated USD 233.2 Million in 2018. The major influencing factors driving the growth of this market are growing popularity of oral appliances in sleep apnea management, technological advancements in oral appliances, a large pool of undiagnosed sleep apnea patients, and growing awareness about sleep apnea. ResMed (US), SomnoMed (Australia), and Whole You (US) are the key players in the sleep apnea oral appliances market. Other players involved in this market are Oventus (Australia), Panthera Dental (Canada), Airway Management (US), Apnea Sciences (US), DynaFlex (US), OravanOSA (US), and Myerson (US).
The global cerebrospinal fluid management market is projected to reach USD 1.56 Billion by 2022 from an estimated USD 1.26 Billion in 2017, at a CAGR of 4.4% during the forecast period. The growth of this market is majorly driven by factors such as the growing geriatric population and the high prevalence of hydrocephalus and the subsequent increase in the number of shunting procedures. The key players in the global cerebrospinal fluid (CSF) management market are Medtronic (Ireland), Integra (US), B. Braun (Germany), DePuy Synthes (US), Spiegelberg GmbH & Co. KG (Germany), SOPHYSA (France), Natus Medical Incorporated (US), Dispomedica GmbH (Germany), Delta Surgical Limited (UK), Argi Grup (Turkey), Moller Medical GmbH (Germany), G. SURGIWEAR LTD. (India), and Wellong Instruments Co., Ltd. (Taiwan).
The laparoscopic and open hernia mesh repair surgery market is projected to reach USD 3.53 Billion by 2022 from USD 3.18 Billion in 2017, at a CAGR of 2.1% during the forecast period. The increasing adoption of mesh in Hernia Repair surgeries, rising geriatric population, new product developments, and efficient reimbursement system in developed countries are the major factors driving the growth of the hernia mesh repair surgery market during the forecast period. The major players in the hernia mesh repair surgery market profiled in this report are Medtronic (Ireland), Johnson & Johnson (US), B. Braun (Germany), C. R. Bard (US), and W.L. Gore (US).
The global plastic surgery instruments market is expected to reach USD 1,479.0 Million by 2023 from USD 1,002.0 Million in 2018, at a CAGR of 8.1%. Increasing awareness and demand for cosmetic surgeries, growing number of age-related surgeries across the globe, and increasing incidence of cancer are the key drivers of the global plastic surgery instruments market. The plastic surgery instruments market is highly fragmented with the presence of several large as well as emerging players. Prominent players in the plastic surgery instruments market include Sklar Surgical Instruments (US), KLS Martin Group (Germany), Integra LifeSciences Corporation (US), Tekno-Medical Optik-Chirurgie GmbH (Germany), KARL STORZ GmbH & Co. KG (Germany), Zimmer Biomet (US), B. Braun Melsungen AG (Germany), BMT Medizintechnik GmbH (Germany), Anthony Products, Inc. (US), Bolton Surgical Ltd. (UK), Surgicon Pvt. Ltd. (Pakistan), and Blink Medical (UK).
The global biomarker technologies market is expected to reach USD 74.51 Billion in 2022 from USD 42.88 Billion in 2016, at a CAGR of 9.7% during the forecast period. The base year considered for the study is 2016 and the forecast period is from 2017 to 2022. The key players in the biomarker technologies market are Thermo Fisher Scientific (US), Agilent Technologies (US), Roche (Switzerland), Danaher Corporation (US), Waters Corporation (US), Shimadzu Corporation (Japan), and Bio-Rad Laboratories (US).
The EMEA 3D CBCT systems market is projected to reach USD 300.4 Million by 2023 from USD 194.3 Million in 2018, at a CAGR of 9.0%. The growing number of dentists is one of the major drivers for the growth of the dental CBCT market in this region. This increase, along with the subsequent establishment of new clinics and rising government spending on healthcare, has contributed to a growing demand for dental equipment like CBCT systems. The key players in the EMEA 3D CBCT systems market are Danaher Corporation (US), DENTSPLY SIRONA (US), Carestream Dental (US), Planmeca Group (Finland), VATECH (South Korea), CEFLA (Italy), J. MORITA CORPORATION (Japan), ACTEON GROUP (France), Asahi Roentgen (Japan), and Genoray (South Korea).
The global sternal closure systems market is projected to reach USD 2.61 Billion by 2023 from USD 2.02 Billion in 2018, at a CAGR of 5.2% during the forecast period. Growing availability of medical reimbursements across major markets, technological advancements in sternotomy techniques, and increased target patient population with the subsequent increase in the number of surgical procedures are expected to drive the demand for sternal closure systems during the study period. As of 2017, the major players in the sternal closure systems market are DePuy Synthes (US), Zimmer Biomet Holdings (US), and A&E Medical (US). Other players in this market include KLS Martin Group (US), Orthofix International N.V. (US), ABYRX (US), Acute Innovations (US), Kinamed Incorporated (US), Praesidia Srl (Italy), and IDEAR S.R.L. (Argentina) among others.
The veterinary pain management market is projected to reach USD 1.66 Billion by 2023 from USD 1.13 Billion in 2018, at a CAGR of 8.0% during the forecast period. Factors such as growth in companion animal adoption, increasing number of veterinary practitioners and their rising income levels in developed economies, growing prevalence of animal disease causing pain and inflammation, and the rising adoption of pet insurance with growing animal health expenditure are expected to drive the growth of the market. However, increasing pet care costs may be a key restraining factor for the market in the next five years. The prominent players in the veterinary pain management market are Zoetis (US), Merck Animal Health (US), Elanco (US), Chanelle (Ireland), Boehringer Ingelheim (Germany), Vetoquinol (France), Bayer (Germany), Norbrook (Ireland), Ceva Santé Animale (France), K-Laser (US), Assisi (US), and Dechra Pharmaceuticals (UK). New product launches and acquisitions were the major strategies adopted by these payers to maintain their positions in the veterinary pain management market
Angiographic catheters market is expected to reach USD 1,402.8 million by 2022 from USD 922.1 million in 2016 and, at a CAGR of 7.4%. The base year for this study is 2016 and the forecast period is 2017–2022. Increasing number of Cath labs in APAC, incidences of CVDs and preference for minimally invasive surgeries are few of the reasons for the growth of this market
The global MRI systems market is projected to reach USD 7.09 Billion by 2023 from USD 5.85 Billion in 2018, at a CAGR of 3.9%. Some key factors driving market growth include the increasing geriatric population, rising awareness about the benefits of early diagnosis, and the introduction of technologically advanced MRI systems with better image quality and high throughput. Factors such as novel application areas such as detection of metastasis in cancer, hybrid MRI systems and emerging markets are expected to offer lucrative growth opportunities for players in the MRI systems market. The major players in the global MRI systems market are Siemens Healthineers (Germany), GE Healthcare (US), Phillips (Netherlands), Hitachi (Japan), and Canon Medical Systems (Japan).
The global occlusion devices market is projected to reach USD 3.55 Billion by 2023 from USD 2.74 Billion in 2018, at a CAGR of 5.3%. The growth witnessed by occlusion devices is mainly driven by the growing target patient population, continuous product launches by major manufacturers, increasing availability of medical reimbursements for occlusion devices across developed countries, and rising adoption of minimally invasive surgical procedures across major countries. Major players operating in the market include Boston Scientific (US), Medtronic (Ireland), Terumo (Japan), Stryker Corporation (US), and Penumbra (US). Other prominent players present in this market are Abbott (US), Cardinal Health (US), B. Braun (Germany), Asahi Intecc (Japan), C.R. Bard (US), Cook Group (US), Angiodynamics (US), and Acrostak (US).
The global surgical drapes and gowns market is expected to reach USD 3.14 Billion by 2023 from USD 2.47 Billion in 2018, at a CAGR of 4.9%. Major industry players launched innovative products to maintain and improve their position in the surgical drapes and gowns market. Cardinal Health (US), 3M (US), Mölnlycke Health Care (Sweden), Halyard Health (US), Thermo Fisher Scientific Inc. (US), Steris plc (US), and Paul Hartmann AG (Germany) have been identified as the key players in this market.
The global neuroendoscopy devices market is expected to reach USD 218.9 Million by 2022 from USD 170.5 Million in 2017, at a CAGR of 5.1% during the forecast period. Factors such favorable government initiatives, rising prevalence of neurological disorders, and benefits of neuroendoscopic surgery over conventional brain surgery are driving the growth of this market. The report segments the global neuroendoscopy devices market into product, application, usability, and region. The neuroendoscopy devices market includes various small and large players. Key players in this market are KARL STORZ (Germany), B.Braun Aesculap (Germany), Ackermann Instrumente (Germany), Adeor Medical (Germany), Hawk (China), Machida (Japan), Tonglu Wanhe Medical (China), Schindler (Germany), Clarus (US), LocaMed (UK), and Visionsense (US).
The global market is projected to reach USD 13.01 billion by 2023 from USD 9.50 billion in 2018, at a CAGR of 6.5%. The growth of this market is driven by the growth in the geriatric population and corresponding age-related dental diseases, rising prevalence of tooth decay and periodontal diseases in the overall population across the globe, increasing willingness to adopt dental cosmetic surgery, and the growing number of implant placing dentists. However, the high cost of premium dental implants and limited reimbursement, and high risk of tooth loss associated with dental bridges may expect to hinder the growth of this market during the forecast period. The dental implants and prosthesis market is fragmented market; and some of the major players competing in this market are Institut Straumann AG (Switzerland), DENTSPLY Sirona Inc. (US), Zimmer Biomet Holdings, Inc. (US), Danaher Corporation (US), AVINENT Implant System (Spain), Henry Schein, Inc. (US), OSSTEM Implant Co., Ltd. (South Korea), DIO Corporation (South Korea), Merz Dental GmbH (Germany), Bicon, LLC (US), Shofu Dental Corporation (Japan), Thommen Medical AG (Switzerland), and Southern Implant (South Africa).
The global urgent care center market is projected to reach USD 25.93 Billion by 2023 from USD 20.07 Billion in 2018, at a CAGR of 5.3% during the forecast period. The growth of this market is driven by factors such as growing investments in urgent care, increasing geriatric population, strategic developments between urgent care providers and hospitals, and affordable care and shorter waiting periods offered by urgent care centers. Concentra (US), MedExpress (US), American Family Care (US), NextCare Holdings (US), and FastMed Urgent Care (US) are the key players in the urgent care center market. Other players involved in this market are CityMD (US), CareNow Urgent Care (US), GoHealth Urgent Care (US), HCA Healthcare UK (UK), Columbia Asia Hospitals (India), International SOS (China), and St. Joseph's Health Care London (Canada).
The global medical display market is projected to reach USD 2.33 Billion by 2023 from USD 1.86 Billion in 2018, at a CAGR of 4.6%. Growing adoption of hybrid ORs, short replacement cycle of medical displays, increasing preference for minimally invasive treatments, and rising number of Diagnostic Imaging centers are the major factors driving the growth of the market. However, market saturation and the increased adoption of refurbished medical displays are expected to restrain the growth of this market to a certain extent. Prominent players in the healthcare medical display market include Barco (Belgium), EIZO (Japan), Sony (Japan), LG Display (South Korea), Novanta (US), FSN Medical (South Korea), Advantech (Taiwan), Quest International (US), STERIS (UK), Jusha Medical (China), Double Black Imaging (US), Dell (US), HP (US), Shenzhen Beacon Display (China), COJE Display (South Korea), and Axiomtek (Taiwan).
The automated blood tube labeler market is expected to reach USD 142.0 Million by 2022 from USD 102.3 Million in 2017, at a CAGR of 6.8% during the forecast period. The scope of the report includes automated tube labeler used to label blood tubes. The specimen transportation box market is expected to reach USD 135.8 Million by 2022 from USD 94.7 Million in 2017, at a CAGR of 7.5% during the forecast period. The base year considered for the study is 2016 and the forecast period is from 2017 to 2022. The automated tube labeler market is dominated by players such as Techno Medica (Japan), Kobayashi Create (Japan), and Inpeco (Switzerland). The major players in specimen transport box market include Sonoco Product Company (US), Greiner Holding (Austria), and Alifax Holdings (Italy).
The transradial access devices market is projected to reach USD 2.18 Billion by 2022 from USD 1.52 Billion in 2017, at a CAGR of 7.5%. The prominent players include Becton, Dickinson and Company (US) and Terumo Corporation (Japan), Teleflex Incorporated (US), Smiths Group Plc (UK), Edward Lifesciences Corporation (US), Medtronic (Ireland), Merit Medical System, Inc. (US), Boston Scientific (US), NIPRO Medical Corporation (US), AngioDynamics (US), Ameco Medical Industries (Egypt), and OSCOR Inc. (US).
The global colposcopy market is expected to reach USD 740.1 Million by 2023 from USD 532.6 Million in 2018, at a CAGR of 6.8%. Market growth can largely be attributed to factors such as the heavy burden of cervical cancer, the rapidly growing geriatric population, and technological advancements in colposcopy. Increasing awareness about gynecological diseases and the emerging Asian markets are expected to present a wide array of growth opportunities for players in the market. Key players in the Colposcopy market include DySIS (US), CooperSurgical (US), Atmos (Germany), Olympus (Japan), Karl Kaps (Germany), McKesson (US), Danaher (US), and Carl Zeiss (Germany).
The global endoscopic vessel harvesting market is projected to reach USD 504.8 Million by 2022 from an estimated USD 420.5 Million in 2017, at a CAGR of 3.7% during the forecast period. The growth of this market is majorly driven by factors such as the increasing prevalence of cardiovascular diseases, growing preference for minimally invasive harvesting owing to advantages it offers over conventional methods, and rising geriatric population. The key players in the global endoscopic vessel harvesting market are Getinge (Sweden), Terumo (Japan), LivaNova (UK), Saphena Medical (US), KARL STORZ (Germany), Cardio Medical (Germany), and Medical Instruments Spa (Italy).
The global cranial fixation and stabilization systems market is expected to reach USD 1.74 Billion by 2022 from USD 1.14 Billion in 2017, at a CAGR of 8.7%. The growth of this market is mainly driven by the increasing prevalence of neurological diseases and high incidence of road accidents and fall related injuries. The cranial fixation and stabilization systems market is highly competitive with the presence of several large as well as emerging players. Prominent players in the cranial fixation and stabilization systems market include B. Braun (Germany), Changzhou Huida (China), DePuy Synthes (US), Evonos (Germany), Integra (US), Jeil Medical (South Korea), KLS Martin (Germany), Medicon (Germany), Medtronic (Ireland), Micromar (Brazil), NEOS Surgery (Spain), OsteoMed (US), Pro Med Instruments (Germany), Stryker (US), and Zimmer Biomet (US).
The global arthroscopy instruments market is projected to reach USD 5.61 Billion by 2022 from USD 4.17 Billion in 2017, at a CAGR of 6.1% during the forecast period. The high incidence of sport-related injuries; technological advancements in arthroscopy products; and efficient reimbursement systems in developed countries are some of the factors driving the growth of the market. The major players of the arthroscopy instruments market are Arthrex (US), Smith & Nephew (UK), DePuy Synthes (US), Stryker (US), Zimmer Biomet (US), CONMED (US), Medtronic (Ireland), Karl Storz (Germany), B. Braun (Germany), Olympus (Japan), Richard Wolf (Germany), MEDICON (Germany), Sklar (US), Millennium (US), and GPC Medical (India).
The global RSV diagnostics market is expected to reach USD 929.2 Million by 2022 from USD 574.3 Million in 2017, at a CAGR of 10.1%. Market growth is primarily driven by the rising burden of RSV infections, growing demand for PoC molecular diagnostic tests for the diagnosis of RSV infections, and increasing approval of RSV diagnostic kits and assays. Key players in the RSV diagnostics market include bioMérieux (France), Becton Dickinson (US), Abbott (US), Roche (Switzerland), Danaher (US), Luminex (US), BioCartis (Belgium), Hologic (US), and Fast Track Diagnostics (Luxembourg).
The global embolic protection devices market is projected to reach USD 604.9 Million by 2023 from USD 405.5 Million in 2018, at a CAGR of 8.3%. Factors such as the rising incidence of cardiovascular and neurovascular diseases, growing funding and investments, launch of technologically advanced embolic protection devices, and rising demand for minimally invasive procedures are expected to drive the growth of the market. On the other hand, product failures and recalls may hinder the overall market growth to a certain extent during the forecast period. The prominent players in the embolic protection devices market are Boston Scientific (US), Medtronic (Ireland), Abbott (US), Cordis (A Cardinal Health Company) (US), Allium Medical (Israel), Contego Medical (US), W.L. Gore & Associates (US), silk Road Medical (US), Claret Medical (US), and AngioSlide (Israel).
The global guidewires market is projected to reach USD 764.0 Million by 2022 from USD 605.2 Million in 2017, at a CAGR of 4.8%. The growth witnessed by guidewires is mainly driven by the growing target patient population, continuous product launches by major manufacturers, increasing availability of medical reimbursements for guidewires across developed countries, and rising adoption of minimally invasive surgical procedures across major countries. Major players operating in the market include Boston Scientific (US), Abbott (US), Medtronic (Ireland), Terumo (Japan), and Cook Group (US). Other prominent players present in this market include Cardinal Health (US), Olympus (Japan), Johnson & Johnson (US), B. Braun (Germany), C.R. Bard (US), Teleflex (US), and Angiodynamics (US).
The global Intraocular Lens Market is projected to reach USD 4.56 Billion by 2022 from USD 3.50 Billion in 2017, at a CAGR of 5.4%. The growth of this market is majorly driven by the growth in the geriatric population and corresponding age-related eye disorders, rising prevalence of eye diseases & diabetes in the overall population across the globe, and increasing government initiatives to control and treat blindness caused by cataract. The key players in the global intraocular lenses market are Alcon, Inc. (US) (Novartis AG (Switzerland)), Bausch + Lomb (US) (Valeant Pharmaceuticals International (Canada)), Johnson & Johnson Vision Care, Inc. (US), Carl Zeiss Meditec (Germany), HOYA Corporation (Japan), STAAR Surgical Company (US), Rayner Intraocular Lenses Limited (UK), PhysIOL (Belgium), Ophtec BV (Netherlands), Swiss Advanced Vision (SAV IOL) (Switzerland), Oculentis GmbH (Germany), NIDEK CO., LTD. (Japan), Aurolab (India), Omni Lens Pvt Ltd. (India), Care Group (India), Hanita Lenses R.C.A Ltd. (Israel), and Fred Hollows Intraocular Laboratory (Eritrea).
The global bone cement and glue market is expected to reach USD 1,322.6 Million by 2022 from USD 993.0 Million in 2017, at a CAGR of 5.9%. The market growth is primarily driven by the growing incidence of sports injuries and increasing developments in Regenerative Medicine field. Key players in the bone cement and glue market include Stryker (US), Zimmer Biomet (US), DePuy Synthes (US), Smith & Nephew (UK), Arthrex (US), DJO Global (US), Exactech (US), TEKNIMED (France), Heraeus Medical (Germany), CryoLife (US), Cardinal Health (US), and Trimph (Australia).
The global vascular grafts market is expected to reach USD 3.80 Billion by 2022 from USD 2.67 Billion in 2017, at a CAGR of 7.3%. Growth in the vascular grafts market is mainly driven by the constant growth in the geriatric population and the corresponding prevalence of aneurysms, increasing incidence of end-stage renal disease, and the growing preference for minimally invasive surgeries. Key players operating in this market are B. Braun (Germany), C. R. Bard (US), Cardinal Health (US), Cook Medical (US), Endologix (US), LeMaitre Vascular (US), Medtronic (Ireland), Maquet (Germany), Terumo (Japan), and Gore Medical (US).
Neuroprostheses uses electrodes to interface with the central or peripheral nervous system to restore lost motor or sensory capabilities. These devices can receive neural signals from the external environment & brain, and convert the signals to restore functions such as loss of hearing and vision. They have applications in cognitive disorders, ophthalmic disorders, motor disorders, and auditory disorders. The global neuroprosthetics market is expected to reach USD 10.48 Billion by 2022 from USD 5.84 Billion in 2017, at a CAGR of 12.4%. Increasing number of neurological disorders, increasing incidence of hearing loss, increasing prevalence of diabetes, and increasing cases of amputation due to the rising number of accidents & injuries are the major driving factors for this market. Some of the major players operating in the neuroprosthetics market are Boston Scientific (US), LivaNova (UK), Medtronic (US), Abbott (US), Cochlear (Australia), and Second sight (US).
The global nerve monitoring system market is projected to reach USD 1.45 Billion by 2022 from USD 1.14 Billion in 2017, at a CAGR of 4.9% during the forecast period. Increased target patient population, clinical benefits associated with nerve monitoring procedures, and the rising use of nerve monitoring in trauma cases are factors expected to drive the demand for nerve monitoring products during the study period. The major players of the nerve monitoring system market are Medtronic (Ireland), NuVasive (US), Nihon Kohden (Japan), Bovie Medical (US), and Natus Medical (US), Checkpoint Surgical (US), Magstim (UK), Inomed (Germany), Erbe Elektromedizin (Germany), Dr. Langer Medical (Germany), EMS Handels (Austria), Neurovision Medical (US), and Halyard Health (Georgia).
The global market for clinical laboratory services is projected to reach $146.41 billion by 2022 from $113.44 billion in 2017, at a CAGR of 5.2%. The major players in the market are Mayo Medical Laboratories (US), Laboratory Corporation of America Holdings (US), Quest Diagnostics Incorporated (US), Spectra Laboratories Inc. (US), DaVita Healthcare Partners (US), Eurofins Scientific (Luxembourg), Unilabs (Switzerland), SYNLAB International (Germany), Bio-Reference Laboratories (US), Sonic Healthcare (UK), Cerba HealthCare (France), and among others
The global amniocentesis Needles market is expected to reach USD 172.8 Million by 2022 from USD 150.6 Million in 2017, at a CAGR of 2.8%. Major industry players acquired companies and business units from other companies to maintain and improve their position in the amniocentesis Needles market. Medtronic (Ireland), BD (US), CooperSurgical (US), Integra LifeSciences (US), Smiths Medical (US), Medline (US), and Cook Medical (US) have been identified as the key players in this market.
The global kidney/renal function test market was valued at USD 558.3 Million in 2016 and expected to reach USD 790.1 Million by 2022, growing at a CAGR of 6.1% during the forecast period. Growth in the kidney function test market can primarily be attributed to factors such as the rising prevalence of kidney disease, growing prevalence of diabetes and hypertension, rapid growth in the geriatric population, and the rise in alcohol consumption are driving the growth of the market. The prominent players in the global kidney function/renal function test market are Abbott (US), Siemens (Germany), Sysmex (Japan), Beckman Coulter (US), Roche (Switzerland), ACON Laboratories, Inc. (US), URIT Medical (China), Nova Biomedical (US), ARKRAY (Japan), OPTI Medical (US), 77 Elektronika (Hungary), and Randox Laboratories (UK).
The global blood glucose monitoring system market was valued at USD 8.10 Billion in 2016 and is projected to reach USD 10.58 Billion by 2022, at a CAGR of 4.8% during the forecast period. Base year considered for the report is 2016 and the forecast period considered for this report is 2017–2022. Rising prevalence of diabetic population, and increasing innovative product launches are factors driving the growth in the blood glucose monitoring system market. The key players in the global blood glucose monitoring system market are Roche (Switzerland), Abbott (US), LifeScan (US), Ascensia (Switzerland), Medtronic (Ireland), Dexcom (US), Ypsomed (Switzerland), B. Braun (Germany), Nipro (Japan), Sanofi (France), ARKRAY (Japan), Prodigy Diabetes Care (US), ACON Laboratories (US), and Nova Biomedical (US).
The global eye exam equipment market is projected to reach USD 3.05 Billion by 2022 from USD 2.29 Billion in 2017, at a CAGR of 6.0% during the forecast period. Growth in this market can primarily be attributed to the rising prevalence of eye diseases, technological advancements in ophthalmic devices, increasing government initiatives to control visual impairment, and increasing healthcare expenditure and rising disposable incomes. The prominent players in the global eye exam equipment market are Carl Ziess (Germany), Haag-Streit (Switzerland), Topcon (Japan), NIDEK (Japan), Heidelberg Engineering (Germany), Escalon (US), Novartis (Switzerland), Valent (Canada), Canon (Japan), Essilor (France), Heine Optotechnik (Germany), and Luneau Technology (France).
The global emergency medical service (EMS) products market is expected to reach USD 25.56 Billion by 2022 from USD 19.01 Billion in 2017, at a CAGR of 6.1%. The market growth is primarily driven by the high demand for emergency care; increasing incidence of trauma injuries; and growing investments by government bodies on healthcare infrastructure development. Key players in the EMS products market include Stryker (US), Medtronic (Ireland), Asahi Kasei (Japan), Cardinal Health (US), Philips (Netherlands), GE Healthcare (US), Smith & Nephew (UK), 3M (US), Smiths Medical (UK), Becton, Dickinson (US), Johnson & Johnson (US), B. Braun (US), and C. R. Bard (US).